High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma

por Wu, Dong-jin, Jiang, Yong-sheng, He, Rui-zhe, Tao, Ling-ye, Yang, Min-wei, Fu, Xue-liang, Yang, Jiang-yu, Zhu, Kun
Publicado 2018

Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas

por Liu, De-Jun, Fu, Xue-Liang, Liu, Wei, Zheng, Lu-Ying, Zhang, Jun-Feng, Huo, Yan-Miao, Li, Jiao, Hua, Rong, Liu, Qiang, Sun, Yong-Wei
Publicado 2017

Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review

por Liu, Wei, Fu, Xue-Liang, Yang, Jian-Yu, Liu, De-Jun, Li, Jiao, Zhang, Jun-Feng, Huo, Yan-Miao, Yang, Min-Wei, Hua, Rong, Sun, Yong-Wei
Publicado 2016

Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma

por Yan, Ting-Ting, Fu, Xue-Liang, Li, Jiao, Bian, Ying-Nan, Liu, De-Jun, Hua, Rong, Ren, Lin-Lin, Li, Cheng-Tao, Sun, Yong-Wei, Chen, Hao-Yan, Fang, Jing-Yuan, Hong, Jie
Publicado 2015

Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma

por Fu, Xue-Liang, Liu, De-Jun, Yan, Ting-Ting, Yang, Jian-Yu, Yang, Min-Wei, Li, Jiao, Huo, Yan-Miao, Liu, Wei, Zhang, Jun-Feng, Hong, Jie, Hua, Rong, Chen, Hao-Yan, Sun, Yong-Wei
Publicado 2016

SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A–c‐Myc axis

por Yang, Jian‐Yu, Huo, Yan‐Miao, Yang, Min‐Wei, Shen, Yang, Liu, De‐Jun, Fu, Xue‐Liang, Tao, Ling‐Ye, He, Rui‐Zhe, Zhang, Jun‐Feng, Hua, Rong, Jiang, Shu‐Heng, Sun, Yong‐Wei, Liu, Wei
Publicado 2021

High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation

por Shen, Chao-qin, Yan, Ting-Ting, Liu, Wei, Zhu, Xiao-qiang, Tian, Xiang-long, Fu, Xue-liang, Hua, Rong, Zhang, Jun-feng, Huo, Yan-miao, Liu, De-jun, Yang, Jian-yu, Sun, Yong-Wei, Fang, Jing-Yuan, Chen, Hao-Yan, Hong, Jie
Publicado 2017

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas

por Yang, Min-Wei, Fu, Xue-Liang, Jiang, Yong-Sheng, Chen, Xiao-Jing, Tao, Ling-Ye, Yang, Jian-Yu, Huo, Yan-Miao, Liu, Wei, Zhang, Jun-Feng, Liu, Pei-Feng, Liu, Qiang, Hua, Rong, Zhang, Zhi-Gang, Sun, Yong-Wei, Liu, De-Jun
Publicado 2019

Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer

por Jiang, Shu-Heng, Wang, Yang, Yang, Jian-Yu, Li, Jun, Feng, Ming-Xuan, Wang, Ya-Hui, Yang, Xiao-Mei, He, Ping, Tian, Guang-Ang, Zhang, Xiao-Xin, Li, Qing, Cao, Xiao-Yan, Huo, Yan-Miao, Yang, Min-Wei, Fu, Xue-Liang, Li, Jiao, Liu, De-Jun, Dai, Miao, Wen, Shan-Yun, Gu, Jian-Ren, Hong, Jie, Hua, Rong, Zhang, Zhi-Gang, Sun, Yong-Wei
Publicado 2015